Table 1.

Summary of studies evaluating alloSCT versus autoSCT in patients with intermediate-risk AML/CR1

Summary of studies evaluating alloSCT versus autoSCT in patients with intermediate-risk AML/CR1
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal